Skip to main content
Caplight Logo









Ovagen Group Limited

Ovagen Group Limited

Private
BallinaHealthcare & Life Scienceshttps://ovagen.ie/

Last Round

Series A

Oct 29, 2024

Total Funding Raised

$9.49M

Company Overview

Ovagen Group Limited is a biotechnology company that has developed a proprietary, scalable platform for producing germ-free embryonated chicken eggs for use in vaccine and biologics manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

germ-free eggsvaccine manufacturingvaccine productionbiomanufacturing substrateSPF eggsspecific pathogen freesterile egg productionavian transgenic technologyIgY antibody servicebio-reactorbiotech supply chainpharma supply chainclean room biologybiotech contract services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ovagen Group Limited Comparables

Compare Ovagen Group Limited with similar companies based on industry and business-model similarity.

Ovagen Group Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AVS Bio
82%
Ovum SPF
81%
EW Group
78%

Ovagen Group Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 29, 2024
VC RoundFeb 3, 2023
GrantJun 22, 2022
VC RoundJun 22, 2022

Ovagen Group Limited Investors

Notable investors and investment history

Ovagen Group Limited investors
InvestorRounds
European Innovation CouncilGrant
Western Development CommissionVC Round, Series A
Boole Angel Investment SyndicateSeries A
European Investment Bank GroupVC Round
European CommissionGrant
Irrus InvestmentsSeries A, VC Round
Halo Business Angel NetworkSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 32% MoM, reaching 2.5K.

  • Nov 7, 2025

    Monthly visitors increased 57% MoM.

Ovagen Group Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ovagen Group Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ovagen Group Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersBallina
Employee Range10
Year Founded2000
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?